The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.
Open accessAbstract
OBJECTIVE--To determine the relevant dose of bendrofluazide for treating mild to moderate hypertension. DESIGN--Double blind parallel group trial of patients who were given placebo for six weeks and then randomly allocated to various doses of bendrofluazide (1.25, 2.5, 5, or 10 mg daily) or placebo for 12 weeks. SETTING--General practices in Zealand, Denmark. PATIENTS--257 Patients with newly diagnosed or previously treated hypertension, aged 25-70, who had a mean diastolic blood pressure of 100-120 mm Hg after receiving placebo for six weeks. MAIN OUTCOME MEASURES--Reduction in diastolic blood pressure and changes in biochemical variables (potassium, urate, glucose, fructosamine, total cholesterol, apolipoprotein A I, apolipoprotein B, and triglyceride concentrations). RESULTS--All doses of bendrofluazide significantly reduced diastolic blood pressure to the same degree (10-11 mm Hg). Clear relations between dose and effect were shown for potassium, urate, glucose, total cholesterol, and apolipoprotein B concentrations. The 1.25 mg dose increased only urate concentrations, whereas the 10 mg dose affected all the above biochemical variables. CONCLUSION--The relevant range of doses of bendrofluazide to treat mild to moderate hypertension is 1.25-2.5 mg a day. Higher doses caused more pronounced adverse biochemical effects including adverse lipid effects. Previous trials with bendrofluazide have used too high doses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pollare, T., Lithell, H., & Berne, C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909283211305 · Cited by 856
Beta-Blockers Versus Diuretics in Hypertensive Men: Main Results from the HAPPHY Trial
Wilhelmsen, L., Berglund, G., Elmfeldt, D., Fitzsimons, T., Holzgreve, H., Hosie, J., H??rnkvist, P.-E., Pennert, K., Tuomilehto, J., & Wedel, H. (1987) · Journal of Hypertension · doi:10.1097/00004872-198710000-00009 · Cited by 463
The Effects of Antihypertensive Agents on Serum Lipids and Lipoproteins
Lardinois, C. K. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.6.1280 · Cited by 175
TOTAL BODY AND SERUM POTASSIUM DURING PROLONGED THIAZIDE THERAPY FOR ESSENTIAL HYPERTENSION
Wilkinson, P. R., Hesp, R., Issler, H., & Raftery, E. B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92432-0 · Cited by 97
Thiazide Therapy Is Not a Cause of Arrhythmia in Patients With Systemic Hypertension
Papademetriou, V., Burris, J. F., Notargiacomo, A., Fletcher, R. D., & Freis, E. D. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380060036009 · Cited by 86
Antihypertensive Effect and Side‐effects of Bendroflumethiazide and Propranolol
Berglund, G. L., Andersson, O., Larsson, O., & Wilhelmsen, L. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb06770.x · Cited by 41
Papademetriou, V., Price, M., Johnson, E., Smith, M. A., & Freis, E. D. (1984) · The American Journal of Cardiology · doi:10.1016/s0002-9149(84)80136-8 · Cited by 18
Cited by
Ramsay, L., Williams, B., Johnston, G., MacGregor, G., Poston, L., Potter, J., Poulter, N., Russell, G., & for the British Hypertension Society (1999) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000917 · Cited by 585
Diuretic Therapy for Hypertension and the Risk of Primary Cardiac Arrest
Siscovick, D. S., Raghunathan, T. E., Psaty, B. M., Koepsell, T. D., Wicklund, K. G., Lin, X., Cobb, L., Rautaharju, P. M., Copass, M. K., & Wagner, E. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302603 · Cited by 434
Diuretics and Risk of Arrhythmic Death in Patients With Left Ventricular Dysfunction
Cooper, H. A., Dries, D. L., Davis, C. E., Shen, Y. L., & Domanski, M. J. (1999) · Circulation · doi:10.1161/01.cir.100.12.1311 · Cited by 377
Prevention and Treatment of the Complications of Diabetes Mellitus
Clark, C. M., & Lee, D. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321807 · Cited by 369
Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP): A Randomized, Controlled Trial
Agarwal, R., Alborzi, P., Satyan, S., & Light, R. P. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.125674 · Cited by 349
Metadata
- Authors
- Carlsen, J. E., Køber, L., Torp-Pedersen, C., & Johansen, P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1990-04-14
- Volume
- 300
- Issue
- 6730
- Pages
- 975-978
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2170390428
- Cited by
- 269
- References
- 7
- FWCI
- 18.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. https://app.cochat.ai/papers/10.1136/bmj.300.6730.975
- The paper
- Carlsen, J. E., Køber, L., Torp-Pedersen, C., & Johansen, P. (1990). Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ. https://doi.org/10.1136/bmj.300.6730.975
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.